Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide
Z Zhao, L Zhu, X Bu, H Ma, S Yang, Y Yang… - Chemical …, 2015 - pubs.rsc.org
The early diagnosis of Alzheimer's disease (AD) is challenging due to the lack of reliable
methods for detecting its biomarkers in the noninvasive biopsies. We used surface plasmon
resonance imaging to identify AD based on the detection of amyloid-beta42 in the serum by …
methods for detecting its biomarkers in the noninvasive biopsies. We used surface plasmon
resonance imaging to identify AD based on the detection of amyloid-beta42 in the serum by …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论